2/22
09:32 am
grcl
Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.
Report
Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.
2/22
09:32 am
grcl
Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.
Report
Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.
2/22
09:29 am
grcl
Rating for GRCL
Report
Rating for GRCL